872 related articles for article (PubMed ID: 27704622)
1. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review.
Lucas López R; Grande Burgos MJ; Gálvez A; Pérez Pulido R
APMIS; 2017 Jan; 125(1):3-10. PubMed ID: 27704622
[TBL] [Abstract][Full Text] [Related]
2. Specific changes of enteric mycobiota and virome in inflammatory bowel disease.
Chu Y; Jiang MZ; Xu B; Wang WJ; Chen D; Li XW; Zhang YJ; Liang J
J Dig Dis; 2018 Jan; 19(1):2-7. PubMed ID: 29266753
[TBL] [Abstract][Full Text] [Related]
3. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
4. Microbiota biodiversity in inflammatory bowel disease.
Comito D; Cascio A; Romano C
Ital J Pediatr; 2014 Mar; 40():32. PubMed ID: 24684926
[TBL] [Abstract][Full Text] [Related]
5. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
7. Oral microbiome composition changes in mouse models of colitis.
Rautava J; Pinnell LJ; Vong L; Akseer N; Assa A; Sherman PM
J Gastroenterol Hepatol; 2015 Mar; 30(3):521-7. PubMed ID: 25180790
[TBL] [Abstract][Full Text] [Related]
8. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
10. Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
Forbes JD; Van Domselaar G; Bernstein CN
Inflamm Bowel Dis; 2016 Apr; 22(4):817-25. PubMed ID: 26937623
[TBL] [Abstract][Full Text] [Related]
11. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
13. Probiotics and antibiotics in IBD.
Sokol H
Dig Dis; 2014; 32 Suppl 1():10-7. PubMed ID: 25531348
[TBL] [Abstract][Full Text] [Related]
14. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiota and inflammatory bowel disease.
Matsuoka K; Kanai T
Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
[TBL] [Abstract][Full Text] [Related]
16. Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs.
Honneffer JB; Minamoto Y; Suchodolski JS
World J Gastroenterol; 2014 Nov; 20(44):16489-97. PubMed ID: 25469017
[TBL] [Abstract][Full Text] [Related]
17. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers.
Said HS; Suda W; Nakagome S; Chinen H; Oshima K; Kim S; Kimura R; Iraha A; Ishida H; Fujita J; Mano S; Morita H; Dohi T; Oota H; Hattori M
DNA Res; 2014 Feb; 21(1):15-25. PubMed ID: 24013298
[TBL] [Abstract][Full Text] [Related]
19. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
20. Role of the microbiota in inflammatory bowel diseases.
Nagalingam NA; Lynch SV
Inflamm Bowel Dis; 2012 May; 18(5):968-84. PubMed ID: 21936031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]